DNA-repair and transcriptional defects drive hematologic malignancies in xeroderma pigmentosum group C patients: A new hypothesis

This publication has 32 references indexed in Scilit:

• Feasibility of Allogeneic Stem Cell Transplantation in Xeroderma Pigmentosum Patients With Hematologic Malignancies, a Report From the SFGM ‐ TC (Société Francophone de Greffe de Moelle et de Thérapie Cellulaire)
  American Journal of Hematology, 2026
• Predicting the number of lifetime divisions for hematopoietic stem cells from telomere length measurements
  iScience, 2023
• Transcription blockage by DNA damage in nucleotide excision repair-related neurological dysfunctions
  Seminars in Cell & Developmental Biology, 2021
• XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1
  Nature Communications, 2018
• Premature Skin Aging Features Rescued by Inhibition of NADPH Oxidase Activity in XPC-Deficient Mice
  Journal of Investigative Dermatology, 2015
• Correlation of Phenotype/Genotype in a Cohort of 23 Xeroderma Pigmentosum-Variant Patients Reveals 12 New Disease-CausingPOLHMutations
  Human Mutation, 2013
• NER Factors Are Recruited to Active Promoters and Facilitate Chromatin Modification for Transcription in the Absence of Exogenous Genotoxic Attack
  Molecular Cell, 2010
• Transcription-coupled DNA repair: two decades of progress and surprises
  Nature Reviews Molecular Cell Biology, 2008
• Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene
  Cell, 1987
• Xeroderma Pigmentosum
  Archives of Dermatology, 1987